Merck

About

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Kenilworth,New Jersey,United States
10001 - max
http://www.merck.com

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $5M
Industries: Biotechnology,Health Care,Medical,Pharmaceutical
Founded date: Jan 1, 1891
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: nyse:MRK
Legal Name: Merck & Co., Inc.

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world.

Merck was founded in 1891 and is headquartered in Kenilworth, NJ.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$5.58M

Merck has raised a total of $5.58M in funding over 2 rounds. Their latest funding was raised on Nov 25, 2018 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 25, 2018	Post-IPO Equity	$586K	1	Private Capital Advisors	—	Detail
Jan 21, 2016	Series Unknown	$5M	1	Gavi, the Vaccine Alliance	—	Detail
Dec 19, 1980	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

27

5

Merck has made 27 investments. Their most recent investment was on Jun 2, 2022, when Canonical Crypto raised $20M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jun 2, 2022 Canonical Crypto	Series Unknown	$20M	Blockchain	—
Mar 30, 2022 Qure AI	Series C	$40M	Artificial Intelligence	—
Sep 14, 2020 Seagen	Post-IPO Equity	$1B	Biotechnology	Yes
Aug 28, 2020 Zapata Computing	Series B	$2.95M	Computer	—
Jul 17, 2020 SAB Biotherapeutics	Series B	$14M	Biotechnology	—

Investors

Number of Lead Investors

Number of Investors

2

Merck is funded by 2 investors. Private Capital Advisors and Gavi, the Vaccine Alliance are the most recent investors.

Investor Name	Lead Investor	Funding Round
Private Capital Advisors	Yes	Post-IPO Equity
Gavi, the Vaccine Alliance	Yes	Series Unknown

Employee Profiles

Number of Employee Profiles

105

Merck has 105 current employee profiles, including Employee Thomas Glocer

Employee

Employee

Executive

Employee

Employee

Exits

Merck has had 9 exits. Merck most notable exits include SAB Biotherapeutics , Themis Bioscience

Date	Company Name	Exit Type	Industry
Oct 25, 2021	SAB Biotherapeutics	IPO	Biotechnology	Detail
May 26, 2020	Themis Bioscience	M&A	Biotechnology	Detail
May 20, 2019	Just - Evotec Biologics	M&A	Biotechnology	Detail
Apr 4, 2019	NGM Biopharmaceuticals	IPO	Biopharma	Detail
Jan 2, 2019	Hangzhou Just Biotherapeutics (Just China)	M&A	Biopharma	Detail

Acquisition

Merck has acquired 33 organizations. Their most recent acquisition was Medco Containment Services Inc. on Nov 19, 1993. They acquired Medco Containment Services Inc. for $6M.

Date Company Name	Industry	Acquisition Type	Price
Nov 19, 1993 Medco Containment Services Inc.	Health Care	acquisition	$ 6M	Detail
May 9, 2006 GlycoFi Inc.	Biotechnology	acquisition	$ 400M	Detail
Oct 30, 2006 Sirna Therapeutics	Biotechnology	acquisition	$ 1.10B	Detail
Nov 9, 2006 Abmaxis, Inc.	Biotechnology	acquisition	$ 80M	Detail
Jul 25, 2007 NovaCardia	Biotechnology	acquisition	$ 366.40M	Detail